These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 3556610
1. Species-specific pharmacology of antiestrogens: role of metabolism. Jordan VC, Robinson SP. Fed Proc; 1987 Apr; 46(5):1870-4. PubMed ID: 3556610 [Abstract] [Full Text] [Related]
2. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity. Murphy CS, Parker CJ, McCague R, Jordan VC. Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879 [Abstract] [Full Text] [Related]
3. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells. Miller MA, Lippman ME, Katzenellenbogen BS. Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162 [Abstract] [Full Text] [Related]
7. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo. Dardes RC, O'Regan RM, Gajdos C, Robinson SP, Bentrem D, De Los Reyes A, Jordan VC. Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645 [Abstract] [Full Text] [Related]
9. Antiestrogen pharmacology and mechanism of action. Katzenellenbogen BS, Miller MA, Eckert RL, Sudo K. J Steroid Biochem; 1983 Jul; 19(1A):59-68. PubMed ID: 6887873 [Abstract] [Full Text] [Related]
10. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites. Liu X, Pisha E, Tonetti DA, Yao D, Li Y, Yao J, Burdette JE, Bolton JL. Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885 [Abstract] [Full Text] [Related]
11. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M. Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749 [Abstract] [Full Text] [Related]
12. Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro. Reddel RR, Murphy LC, Sutherland RL. Cancer Res; 1983 Oct 01; 43(10):4618-24. PubMed ID: 6883318 [Abstract] [Full Text] [Related]
13. Basic guide to the mechanisms of antiestrogen action. MacGregor JI, Jordan VC. Pharmacol Rev; 1998 Jun 01; 50(2):151-96. PubMed ID: 9647865 [Abstract] [Full Text] [Related]
15. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice. Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC. Clin Cancer Res; 2000 May 01; 6(5):2028-36. PubMed ID: 10815929 [Abstract] [Full Text] [Related]
16. Comparison of estrogen receptor DNA binding in untreated and acquired antiestrogen-resistant human breast tumors. Johnston SR, Lu B, Dowsett M, Liang X, Kaufmann M, Scott GK, Osborne CK, Benz CC. Cancer Res; 1997 Sep 01; 57(17):3723-7. PubMed ID: 9288779 [Abstract] [Full Text] [Related]
18. Long-term tamoxifen therapy to control or to prevent breast cancer: laboratory concept to clinical trials. Jordan VC. Prog Clin Biol Res; 1988 Sep 01; 262():105-23. PubMed ID: 3287387 [Abstract] [Full Text] [Related]
19. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells. Sheen YY, Ruh TS, Mangel WF, Katzenellenbogen BS. Cancer Res; 1985 Sep 01; 45(9):4192-9. PubMed ID: 4040807 [Abstract] [Full Text] [Related]